Millie D. Long, Bruce E. Sands 

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Ruben Hernaez, MD, MPH, PhD  Clinical Gastroenterology and Hepatology 
Covering the Cover Gastroenterology
Zachary Junga, Amy Stratton, Jeffrey Laczek 
Pichamol Jirapinyo, Christopher C. Thompson 
Treatment of Esophageal (Noncardiac) Chest Pain: An Expert Review
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Celiac Disease and Persistent Symptoms
A Shocking Cystory Clinical Gastroenterology and Hepatology
Colonic Amyloidosis Clinical Gastroenterology and Hepatology
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010  Tine Jess, Morten Frisch, Jacob Simonsen 
Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review  Marin J. de Jong,
A 5-Year Prospective Observational Study of the Outcomes of International Treatment Guidelines for Crohn's Disease  Garret Cullen, Denise Keegan, Hugh.
Serhat Bor, Gul Kitapcioglu, Peter Dettmar, Tim Baxter 
Ampullary Carcinoid: Diagnostic Challenges and Update on Management
Atopic Characteristics of Adult Patients With Eosinophilic Esophagitis
Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased  Fiona D.M. van Schaik, Martijn G.H.
Jamile' Wakim–Fleming, Mangesh R. Pagadala, Martin S
Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis  Suzanne E. Mahady, Petra Macaskill,
Endoscopic Therapy for Barrett's Esophagus
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q
Liver Test Results Do Not Identify Liver Disease in Adults With α1-Antitrypsin Deficiency  Virginia C. Clark, Renumathy Dhanasekaran, Mark Brantly, Farshid.
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
New Models of Gastroenterology Practice
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases  Michael D.
Issue Highlights Clinical Gastroenterology and Hepatology
David H. Bruining, William J. Sandborn 
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases  Ashwin N. Ananthakrishnan, Christopher.
Rebecca M. Lovell, Alexander C. Ford 
Patient-Reported Outcomes of Cirrhosis
A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?  Andrew D. Rhim, Michael.
Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases  Xavier Roblin, Hubert Marotte, Melanie.
Colorectal Cancer Screening: How to Stop a Moving Target
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population- based Cohort Study With 30 Years of Follow-up Evaluation  Michael.
Alan Bonder, MD, Nezam H. Afdhal, MD 
Antje Timmer, Alexandra Bauer, Axel Dignass, Gerhard Rogler 
Volume 151, Issue 4, Pages (October 2016)
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Javier Oliver, Blanca Rueda, Miguel A
Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis 
Richard Blumberg, Judy Cho, James Lewis, Gary Wu  Gastroenterology 
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Thrombocytopenia With Abnormal Liver Function Tests
Benedetto Mangiavillano, Monica Arena, Enzo Masci 
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Issue Highlights Clinical Gastroenterology and Hepatology
Coloduodenal Fistula in Crohn’s Disease
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
Issue Highlights Clinical Gastroenterology and Hepatology
The Role of Psychosocial Care in Adapting to Health Care Reform
Presentation transcript:

What Is the Role of the Inflammatory Bowel Disease Panel in Diagnosis and Treatment?  Millie D. Long, Bruce E. Sands  Clinical Gastroenterology and Hepatology  Volume 16, Issue 5, Pages 618-620 (May 2018) DOI: 10.1016/j.cgh.2018.02.010 Copyright © 2018 AGA Institute Terms and Conditions

Figure 1 An example diagnostic test: positive predictive value (PPV) and negative predictive value (NPV) as a function of prevalence of disease. For any given test, the lower the prevalence, the lower the PPV. As inflammatory bowel disease is a low prevalence condition in the general population, * even a test with good sensitivity and specificity (>90%) may have a low PPV. ∗In populations with higher prevalence of disease (i.e., symptomatic populations with specific clinical characteristics and/or laboratory abnormalities) the PPV would differ. Clinical Gastroenterology and Hepatology 2018 16, 618-620DOI: (10.1016/j.cgh.2018.02.010) Copyright © 2018 AGA Institute Terms and Conditions